Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji)

Blood

Volumn 87, Issue 3, 1996, Pages 1006-1012

  Kondo, Shinichi ^b   Tokunaga, Fuminori ^b   Kario, Kazuomi ^b   Matsuo, Takefumi ^b   Koide, Takehiko ^a  

^a UNIVERSITY OF HYOGO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN COFACTOR II; MUTANT PROTEIN;

ADULT; AMINO ACID SEQUENCE; ANGINA PECTORIS; ARTICLE; BLOOD CLOTTING FACTOR DEFICIENCY; CASE REPORT; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CROSSED IMMUNOELECTROPHORESIS; FRAMESHIFT MUTATION; HUMAN; IMMUNOPRECIPITATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; SITE DIRECTED MUTAGENESIS;

EID: 0030062348     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.3.1006.bloodjournal8731006     Document Type: Article

References (29)

1. Tollefsen DM, Blank MK: Detection of a new heparin-dependent inhibitor of thrombin in human plasma. J Clin Invest 68:589, 1981
2. Björk I, Danielsson Å: Antithrombin and related inhibitors of coagulation proteinases, in Barrett AJ, Salvesen G (eds): Proteinase Inhibitors. Amsterdam, The Netherlands, Elsevier, 1986, p 489
3. Tollefsen DM, Pestka CA, Monafo WJ: Activation of heparin cofactor II by dermatan sulfate. J Biol Chem 258:6713, 1983
4. Ragg H: A new member of the plasma protease inhibitor gene family. Nucleic Acids Res 14:1073, 1986
5. Blinder MA, Marasa JC, Reynolds CH, Deaven LL, Tollefsen DM: Heparin cofactor II: cDNA sequence, chromosome localization, restriction length polymorphism, and expression in Escherichia coli. Biochemistry 27:752, 1988
6. Hortin G, Tollefsen DM, Strauss AW: Identification of two sites of sulfation of human heparin cofactor II. J Biol Chem 261:15827, 1986
7. Ragg H, Preibisch G: Structure and expression of the gene coding for the human serpin hLS2. J Biol Chem 263:12129, 1988
8. Herzog R, Lutz S, Blin N, Marasa JC, Blinder MA, Tollefsen DM: Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11. Biochemistry 30:1350, 1991
9. Lane DA, Olds RJ, Boisclair M, Chowdhury V, Thein SL, Cooper DN, Blajchman M, Perry D, Emmerich J, Aiach M: Anti-thrombin III Mutation Database: First Update. Thromb Haemost 70:361, 1993
10. Blinder MA, Andersson TR, Ablidgaard U, Tollefsen DM: Heparin cofactor II Oslo: Mutation of Arg-189 to His decreases the affinity for dermatan sulfate. J Biol Chem 264:5128, 1989
11. Matsuo T, Kario K, Sakamoto S, Yamada T, Miki T, Hirase T, Kobayashi H: Hereditary heparin cofactor II deficiency and coronary artery disease. Thromb Res 65:495, 1992
12. Tran TH, Marbert GA, Duckert F: Association of hereditary heparin co-factor II deficiency with thrombosis. Lancet 2:413, 1985
13. Sie P, Dupouy D, Pichon J, Boneu B: Constitutional heparin co-factor II deficiency associated with recurrent thrombosis. Lancet 2:414, 1985
14. Weisdorf DJ, Edson JR: Recurrent venous thrombosis associated with inherited deficiency of heparin cofactor II. Br J Haematol 77:125, 1991
15. Awidi AS, Abu KM, Herzallah U, Abu RA, Shannak MM, Abu OT, Al TI, Anshasi B: Hereditary thrombophilia among 217 consecutive patients with thromboembolic disease in Jordan. Am J Hematol 44:95, 1993
16. Yamagishi R, Niwa M, Kondo S, Sakuragawa N, Koide T: Purification and biological property of heparin cofactor II: Activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans. Thromb Res 36:633, 1984
17. Chen C, Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745, 1987
18. Takebe Y, Seiki M, Fujikawa J, Hoy P, Yokota K, Arai K, Yoshida M, Arai N: SRα promoter: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 8:466, 1988
19. Tokunaga F, Wakabayashi S, Koide T: Warfarin causes the degradation of protein C precursor in the endoplasmic reticulum. Biochemistry 34:1163, 1995
20. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
21. Schägger H, von Jagow G: Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166:368, 1987
22. Gretch DR, Suter M, Stinski MF: The use of biotinylated monoclonal antibodies and streptoavidin affinity chromatography to isolate herpesvirus hydrophobic proteins or glycoproteins. Anal Biochem 163:270, 1987
23. Conyers SM, Kidwell DA: Chromogenic substrates for horse-radish peroxidase. Anal Biochem 192:207, 1991
24. Daly DM, Perry DJ, Harper PL, Carrell RW: The molecular basis of quantitative antithrombin deficiency in 8 unrelated families. Br J Haematol 80:15, 1992 (abstr)
25. Van Deerlin VMD, Tollefsen DM: The N-terminal acidic domain of heparin cofactor II mediates the inhibition of α-thrombin in the presence of glycosaminoglycans. J Biol Chem 266:20223, 1991
26. ElAwady M, Chowdhury JR, Kesari K, van Es H, Jansen PLM, Lederstein M, Arias IM, Chowdhury NR: Mechanism of the lack of induction of UDP-glucuronosyltransferase activity in Gunn rats by 3-methylcholanthrene: Identification of a truncated enzyme. J Biol Chem 265:10752, 1990
27. 2-plasmin inhibitor: A frameshift mutation leading to elongation of the deduced amino acid sequence. J Clin Invest 83:1598, 1989
28. Brodbeck RM, Brown JL. Secretion of α1-proteinase inhibitor requires an almost full length of molecule. J Biol Chem 267:294, 1992
29. 2-plasmin inhibitor from human plasma and culture media of Hep G2 cells. Biochem Biophys Res Commun 200:417, 1994